Make it two days in a row of big gains for Biohaven Ltd. (NYSE: BHVN). The momentum is primarily due to the company's new beginning after being spun off from Biohaven Pharmaceutical. Pfizer (NYSE: PFE) closed on its acquisition of Biohaven Pharmaceutical on Monday, with Biohaven Ltd. created as a spin-off before the transaction finalized.
Exelixis' (EXEL) efforts to expand Cabometyx's label and develop additional drugs to expand its portfolio should reap rewards for the company.
Three dividend stocks that stand out as being among the most promising buys right now are Pfizer (NYSE: PFE), Suncor Energy (NYSE: SU), and Verizon Communications (NYSE: VZ). Pharmaceutical giant Pfizer is down 26% this year, performing in line with the broader markets.